Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of a Mitomycin C Prodrug, for Use in Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.058

Related search